Company · CIK 0000887247 · SIC 2834 — Pharmaceutical Preparations
Adamis Pharmaceuticals Corp · ADMP
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 21, 2019 MForm 4 → | Feb 25, 7:17 pm EST | David J. MarguglioSVP and Chief Business Officer, Director | 22,258 | — | — | 401,013 | — | plan? |
| Feb 21, 2019 MForm 4 → | Feb 25, 7:16 pm EST | Ronald B. MossChief Medical Officer | 13,911 | — | — | 291,643 | — | plan? |
| Feb 21, 2019 MForm 4 → | Feb 25, 7:14 pm EST | Karen K. DanielsVP of Operations | 13,911 | — | — | 193,855 | — | plan? |
| Feb 21, 2019 MForm 4 → | Feb 25, 7:13 pm EST | Robert O HopkinsChief Financial Officer | 22,258 | — | — | 356,807 | — | plan? |
| Feb 21, 2019 MForm 4 → | Feb 25, 7:10 pm EST | Dennis J Carlo Ph.D.President & CEO, Director | 27,822 | — | — | 388,883 | — | plan? amended |
| Jan 30, 2019 AForm 4 → | Feb 1, 9:45 pm EST | Robert O HopkinsChief Financial Officer | 277,732 | — | — | 334,549 | — | plan? |
| Jan 30, 2019 AForm 4 → | Feb 1, 9:44 pm EST | Dennis J Carlo Ph.D.President & CEO, Director | 347,165 | — | — | 361,061 | — | plan? |
| Jan 30, 2019 AForm 4 → | Feb 1, 9:43 pm EST | Karen K. DanielsVP of Operations | 173,583 | — | — | 179,944 | — | plan? |
| Jan 30, 2019 AForm 4 → | Feb 1, 9:36 pm EST | David J. MarguglioSr VP of Business Development, Director | 277,732 | — | — | 378,755 | — | plan? |
| Jan 30, 2019 AForm 4 → | Feb 1, 9:28 pm EST | Ronald B. MossChief Medical Officer | 277,732 | — | — | 277,732 | — | plan? |
| Dec 17, 2018 GForm 5 → | Feb 12, 2019, 6:45 pm EST | Dennis J Carlo Ph.D.President & CEO, Director | 43,000 | — | — | 250,709 | — | plan? |
| Jun 4, 2018 GForm 5 → | Feb 12, 2019, 6:44 pm EST | Eddie Wabern GloverCEO of US Compounding, Inc. | 41,666 | — | — | 741,668 | — | plan? |
| Dec 27, 2017 GForm 5 → | Feb 14, 2018, 7:04 pm EST | David J. MarguglioSenior V.P. of Business Dev., Director | 1,600 | — | — | 101,023 | — | plan? |
| Dec 20, 2017 GForm 5 → | Feb 14, 2018, 7:03 pm EST | Dennis J Carlo Ph.D.President & CEO, Director | 40,000 | — | — | 293,709 | — | plan? |
| Feb 15, 2017 GForm 5 → | Feb 14, 2018, 7:04 pm EST | Eddie Wabern GloverCEO of U.S. Compounding, Inc. | 83,332 | — | — | 783,334 | — | plan? |
| Dec 29, 2016 GForm 5 → | Feb 10, 2017, 6:38 pm EST | Dennis J Carlo Ph.D.President & CEO, Director | 25,000 | — | — | 333,709 | — | plan? |
| Jun 2, 2016 SForm 4 → | Jun 6, 4:11 pm EDT | David J. MarguglioSR. VP of Corporate Devel., Director | 700 | $9.00 | $6,301 | 101,527 | −0.68% | plan? |
| May 25, 2016 AForm 4 → | May 27, 5:18 pm EDT | Richard C WilliamsDirector | 150,000 | — | — | 189,918 | — | plan? |
| May 25, 2016 AForm 4 → | May 27, 4:50 pm EDT | Robert B RothermelDirector | 100,000 | — | — | 127,000 | — | plan? |
| May 25, 2016 AForm 4 → | May 27, 4:44 pm EDT | William C DenbyDirector | 100,000 | — | — | 102,500 | — | plan? |
| May 16, 2016 SForm 4 → | May 18, 6:57 pm EDT | David J. MarguglioSR VP OF CORPORATE DEVELOPMENT, Director | 4,000 | $8.08 | $32,339 | 102,227 | −3.77% | plan? |
| May 9, 2016 SForm 4/A → | May 18, 6:24 pm EDT | David J. MarguglioSR VP OF CORPORATE DEVELOPMENT, Director | 6,000 | $10.00 | $60,000 | 106,227 | −5.35% | plan? |
| May 9, 2016 SForm 4 → | May 11, 4:32 pm EDT | David J. MarguglioSR VP of Corporate Development, Director | 4,860 | $10.00 | $48,600 | 106,227 | −4.37% | plan? amended |
| May 4, 2016 SForm 4 → | May 6, 4:47 pm EDT | David J. MarguglioSR VP of Corporate Development, Director | 4,860 | $9.17 | $44,577 | 112,227 | −4.15% | plan? |
| May 3, 2016 SForm 4 → | May 5, 5:18 pm EDT | David J. MarguglioSR VP of Corporate Development, Director | 1,140 | $9.00 | $10,260 | 117,087 | −0.96% | plan? |
| Apr 14, 2016 SForm 4 → | Apr 18, 5:27 pm EDT | David J. MarguglioSR VP of Corporate Development, Director | 12,000 | $7.52 | $90,216 | 118,227 | −9.21% | plan? |
| Apr 13, 2016 AForm 4 → | Apr 14, 2:57 pm EDT | Eddie Wabern GloverCEO of U.S. Compounding, Inc. | 866,666 | — | — | 866,666 | — | plan? |
| Aug 13, 2015 PForm 4 → | Aug 17, 5:30 pm EDT | Richard C WilliamsDirector | 9,800 | $3.26 | $31,930 | 39,918 | +32.5% | plan? |
| Aug 13, 2015 PForm 4 → | Aug 17, 5:29 pm EDT | Robert B RothermelDirector | 7,000 | $3.33 | $23,294 | 27,000 | +35.0% | plan? |
| Apr 20, 2015 SForm 4 → | Apr 22, 6:19 pm EDT | David J. MarguglioSr VP of Business Development, Director | 200 | $5.00 | $1,000 | 140,323 | −0.14% | plan? |
| Apr 17, 2015 SForm 4 → | Apr 20, 4:28 pm EDT | David J. MarguglioSr VP of Business Development, Director | 100 | $5.01 | $501 | 140,523 | −0.07% | plan? |
| Apr 16, 2015 SForm 4 → | Apr 17, 6:00 pm EDT | David J. MarguglioSr VP of Business Development, Director | 700 | $5.00 | $3,501 | 140,623 | −0.50% | plan? |
| Apr 13, 2015 SForm 4 → | Apr 15, 5:48 pm EDT | David J. MarguglioSr VP of Business Development, Director | 2,200 | $5.01 | $11,024 | 141,323 | −1.53% | plan? |
| Apr 2, 2015 GForm 5 → | Feb 12, 2016, 6:26 pm EST | David J. MarguglioSenior Vice President, Director | 20,768 | — | — | 130,227 | — | plan? |
| Mar 4, 2015 SForm 4 → | Mar 5, 11:46 am EST | David J. MarguglioSr VP of Business Development, Director | 11,800 | $7.09 | $83,662 | 143,523 | −7.60% | plan? |
| Mar 2, 2015 SForm 4 → | Mar 3, 8:56 pm EST | David J. MarguglioSr VP of Business Development, Director | 7,000 | $6.45 | $45,150 | 155,323 | −4.31% | plan? |
| Feb 13, 2015 SForm 4 → | Feb 13, 5:24 pm EST | Ahmed Shayan Fazlur Rahman +110% Owner | 12,076 | $6.41 | $77,395 | 1,635,312 | −0.73% | plan? |
| Feb 10, 2015 SForm 4 → | Feb 12, 4:38 pm EST | Ahmed Shayan Fazlur Rahman +110% Owner | 38,000 | $6.40 | $243,168 | 1,647,388 | −2.25% | plan? |
| Jan 30, 2015 SForm 4 → | Feb 3, 6:51 pm EST | Ahmed Shayan Fazlur Rahman +110% Owner | 30,000 | $6.75 | $202,550 | 1,685,388 | −1.75% | plan? |
| Jan 9, 2015 GForm 5 → | Feb 16, 2016, 6:16 pm EST | Dennis J Carlo Ph.D.President & CEO, Director | 50,000 | — | — | 358,709 | — | plan? |
| Jan 8, 2015 SForm 4 → | Jan 9, 4:44 pm EST | David J. MarguglioSr VP of Business Development, Director | 200 | $7.00 | $1,400 | 164,273 | −0.12% | plan? |
| Jan 5, 2015 SForm 4 → | Jan 6, 4:51 pm EST | David J. MarguglioSenior VP of Bus. Development, Director | 7,000 | $6.18 | $43,260 | 164,473 | −4.08% | plan? |
| Dec 24, 2014 GForm 5 → | Feb 17, 2015, 5:30 pm EST | David J. MarguglioSenior Vice President, Director | 1,950 | — | — | 169,523 | — | plan? |
| Feb 27, 2014 GForm 5/A → | Feb 16, 2016, 6:12 pm EST | Dennis J Carlo Ph.D.President & CEO, Director | 841,537 | — | — | 408,709 | — | plan? |
| Feb 27, 2014 GForm 5 → | Feb 17, 2015, 5:31 pm EST | Dennis J Carlo Ph.D.President & CEO, Director | 24,119 | — | — | 418,219 | — | plan? amended |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 21, 2019 MForm 4/A → | Mar 12, 4:11 pm EDT | Dennis J Carlo Ph.D.President & CEO, Director | 27,822 | — | — | 55,645 | — | |
| Feb 21, 2019 MForm 4 → | Feb 25, 7:17 pm EST | David J. MarguglioSVP and Chief Business Officer, Director | 22,258 | — | — | 44,515 | — | |
| Feb 21, 2019 MForm 4 → | Feb 25, 7:16 pm EST | Ronald B. MossChief Medical Officer | 13,911 | — | — | 27,822 | — | |
| Feb 21, 2019 MForm 4 → | Feb 25, 7:14 pm EST | Karen K. DanielsVP of Operations | 13,911 | — | — | 27,822 | — | |
| Feb 21, 2019 MForm 4 → | Feb 25, 7:13 pm EST | Robert O HopkinsChief Financial Officer | 22,258 | — | — | 44,515 | — | |
| Feb 21, 2019 MForm 4 → | Feb 25, 7:10 pm EST | Dennis J Carlo Ph.D.President & CEO, Director | 27,822 | — | — | 55,645 | — | amended |
| Jan 30, 2019 AForm 4 → | Feb 1, 9:35 pm EST | Richard C WilliamsDirector | 30,000 | — | — | 30,000 | — | |
| Jan 30, 2019 AForm 4 → | Feb 1, 9:34 pm EST | Robert B RothermelDirector | 30,000 | — | — | 30,000 | — | |
| Jan 30, 2019 AForm 4 → | Feb 1, 7:11 pm EST | William C DenbyDirector | 30,000 | — | — | 30,000 | — | |
| Jul 9, 2018 AForm 4 → | Jul 11, 4:53 pm EDT | William C DenbyDirector | 30,000 | — | — | 30,000 | — | |
| Jul 9, 2018 AForm 4 → | Jul 11, 4:50 pm EDT | Richard C WilliamsDirector | 30,000 | — | — | 30,000 | — | |
| Jul 9, 2018 AForm 4 → | Jul 11, 4:46 pm EDT | Robert B RothermelDirector | 30,000 | — | — | 30,000 | — | |
| Feb 21, 2018 AForm 4 → | Feb 23, 6:06 pm EST | Eddie Wabern GloverCEO of US Compounding, Inc. | 35,000 | — | — | 35,000 | — | |
| Feb 21, 2018 AForm 4 → | Feb 23, 6:04 pm EST | Dennis J Carlo Ph.D.President & CEO, Director | 250,401 | — | — | 83,467 | — | |
| Feb 21, 2018 AForm 4 → | Feb 23, 5:59 pm EST | Ronald B. MossChief Medical Officer | 125,200 | — | — | 41,733 | — | |
| Feb 21, 2018 AForm 4 → | Feb 23, 5:58 pm EST | David J. MarguglioSr VP of Business Development, Director | 200,320 | — | — | 66,773 | — | |
| Feb 21, 2018 AForm 4 → | Feb 23, 5:57 pm EST | Karen K. DanielsVP of Operations | 125,200 | — | — | 41,733 | — | |
| Feb 21, 2018 AForm 4 → | Feb 23, 5:53 pm EST | Robert O HopkinsChief Financial Officer | 200,320 | — | — | 66,773 | — | |
| Feb 21, 2018 AForm 4 → | Feb 23, 5:53 pm EST | Thomas MollVP of Research | 125,200 | — | — | 41,733 | — | |
| Jun 8, 2017 AForm 4 → | Jun 12, 4:16 pm EDT | Richard C WilliamsDirector | 30,000 | — | — | 30,000 | — | |
| Jun 8, 2017 AForm 4 → | Jun 12, 4:15 pm EDT | Robert B RothermelDirector | 30,000 | — | — | 30,000 | — | |
| Jun 8, 2017 AForm 4 → | Jun 12, 4:15 pm EDT | William C DenbyDirector | 30,000 | — | — | 30,000 | — | |
| Mar 1, 2017 AForm 4 → | Mar 3, 7:07 pm EST | Karen K. DanielsVP of Operations | 150,000 | — | — | 150,000 | — | |
| Mar 1, 2017 AForm 4 → | Mar 3, 7:04 pm EST | Thomas MollVP of Research | 150,000 | — | — | 150,000 | — | |
| Mar 1, 2017 AForm 4 → | Mar 3, 6:55 pm EST | David J. MarguglioSr VP of Business Development, Director | 200,000 | — | — | 200,000 | — | |
| Mar 1, 2017 AForm 4 → | Mar 3, 6:53 pm EST | Robert O HopkinsChief Financial Officer | 200,000 | — | — | 200,000 | — | |
| Mar 1, 2017 AForm 4 → | Mar 3, 6:49 pm EST | Dennis J Carlo Ph.D.President & CEO, Director | 250,000 | — | — | 250,000 | — | |
| Feb 28, 2017 AForm 4 → | Mar 16, 6:42 pm EDT | Ronald B. MossChief Medical Officer | 210,000 | — | — | 210,000 | — | late |
| Feb 7, 2017 AForm 4 → | Feb 9, 5:01 pm EST | Thomas MollVP of Research | 110,000 | — | — | 110,000 | — | |
| Feb 7, 2017 AForm 4 → | Feb 9, 4:54 pm EST | Dennis J Carlo Ph.D.President & CEO, Director | 477,000 | — | — | 477,000 | — | |
| Feb 7, 2017 AForm 4 → | Feb 9, 4:49 pm EST | Karen K. DanielsVP of Operations | 110,000 | — | — | 110,000 | — | |
| Feb 7, 2017 AForm 4 → | Feb 9, 4:44 pm EST | David J. MarguglioSr VP of Business Development, Director | 176,000 | — | — | 176,000 | — | |
| Feb 7, 2017 AForm 4 → | Feb 9, 4:39 pm EST | Robert O HopkinsChief Financial Officer | 110,000 | — | — | 110,000 | — | |
| May 25, 2016 AForm 4 → | May 27, 5:27 pm EDT | Eddie Wabern GloverCEO of U.S. Compounding, Inc. | 70,000 | — | — | 70,000 | — | |
| May 25, 2016 AForm 4 → | May 27, 5:18 pm EDT | Richard C WilliamsDirector | 30,000 | — | — | 30,000 | — | |
| May 25, 2016 AForm 4 → | May 27, 4:50 pm EDT | Robert B RothermelDirector | 30,000 | — | — | 30,000 | — | |
| May 25, 2016 AForm 4 → | May 27, 4:44 pm EDT | William C DenbyDirector | 30,000 | — | — | 30,000 | — | |
| Jan 25, 2016 AForm 4 → | Jan 27, 4:25 pm EST | Robert O HopkinsChief Financial Officer | 67,183 | — | — | 67,183 | — | |
| Jan 25, 2016 AForm 4 → | Jan 27, 4:23 pm EST | David J. MarguglioSr VP of Business Development, Director | 107,493 | — | — | 107,493 | — | |
| Jan 25, 2016 AForm 4 → | Jan 27, 4:19 pm EST | Thomas MollVP of Research | 67,183 | — | — | 67,183 | — | |
| Jan 25, 2016 AForm 4 → | Jan 27, 4:15 pm EST | Karen K. DanielsVP of Operations | 67,183 | — | — | 67,183 | — | |
| Jan 25, 2016 AForm 4 → | Jan 27, 4:11 pm EST | Dennis J Carlo Ph.D.President & CEO, Director | 442,367 | — | — | 442,367 | — | |
| May 15, 2015 AForm 4 → | May 18, 4:00 pm EDT | Robert B RothermelDirector | 20,000 | — | — | 20,000 | — | |
| May 15, 2015 AForm 4 → | May 18, 3:56 pm EDT | Richard C WilliamsDirector | 20,000 | — | — | 20,000 | — | |
| May 15, 2015 AForm 4 → | May 18, 3:55 pm EDT | William C DenbyDirector | 20,000 | — | — | 20,000 | — | |
| Jan 23, 2015 AForm 4 → | Jan 27, 5:54 pm EST | Dennis J Carlo Ph.D.President & CEO, Director | 232,103 | — | — | 232,103 | — | |
| Jan 23, 2015 AForm 4 → | Jan 27, 5:53 pm EST | Karen K. DanielsVP of Operations | 65,050 | — | — | 65,050 | — | |
| Jan 23, 2015 AForm 4 → | Jan 27, 5:53 pm EST | Robert O HopkinsChief Financial Officer | 65,050 | — | — | 65,050 | — | |
| Jan 23, 2015 AForm 4 → | Jan 27, 5:52 pm EST | Thomas MollVP of Research | 65,050 | — | — | 65,050 | — | |
| Jan 23, 2015 AForm 4 → | Jan 27, 5:51 pm EST | David J. MarguglioSenior Vice President, Director | 119,910 | — | — | 119,910 | — |